BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30708194)

  • 21. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
    Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIM-3 expression identifies a distinctive PD-1
    Li L; Ma Y; Xu Y; Maerkeya K
    Int Immunopharmacol; 2018 Apr; 57():139-146. PubMed ID: 29482158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CD226-ERK1/2-LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy-resistant acute myeloid leukemia blasts and leukemia stem cells.
    Wu K; Wang LM; Liu M; Xiu Y; Hu Y; Fu S; Huang H; Xu B; Xiao H
    Cancer Sci; 2021 Aug; 112(8):3233-3242. PubMed ID: 34107135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.
    Poccia F; Malkovsky M; Pollak A; Colizzi V; Sireci G; Salerno A; Dieli F
    Mol Med; 1999 Jul; 5(7):471-6. PubMed ID: 10449808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective Treg response in acute kidney injury was caused by a reduction in TIM-3
    Dong Q; Cai C; Gao F; Chen P; Gong W; Shen M
    Immunol Invest; 2019 Jan; 48(1):27-38. PubMed ID: 29985717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
    Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors.
    Joalland N; Chauvin C; Oliver L; Vallette FM; Pecqueur C; Jarry U; Scotet E
    J Immunother; 2018 Jun; 41(5):224-231. PubMed ID: 29683891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells.
    Dunne MR; Mangan BA; Madrigal-Estebas L; Doherty DG
    Mediators Inflamm; 2010; 2010():704941. PubMed ID: 21403900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
    Devilder MC; Maillet S; Bouyge-Moreau I; Donnadieu E; Bonneville M; Scotet E
    J Immunol; 2006 Feb; 176(3):1386-93. PubMed ID: 16424165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells.
    Caccamo N; La Mendola C; Orlando V; Meraviglia S; Todaro M; Stassi G; Sireci G; Fournié JJ; Dieli F
    Blood; 2011 Jul; 118(1):129-38. PubMed ID: 21505189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
    Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
    Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
    J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma.
    Sawaisorn P; Gaballa A; Saimuang K; Leepiyasakulchai C; Lertjuthaporn S; Hongeng S; Uhlin M; Jangpatarapongsa K
    Sci Rep; 2024 Jan; 14(1):1291. PubMed ID: 38221530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
    Lafont V; Liautard J; Liautard JP; Favero J
    J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
    Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
    J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.
    Beatson RE; Parente-Pereira AC; Halim L; Cozzetto D; Hull C; Whilding LM; Martinez O; Taylor CA; Obajdin J; Luu Hoang KN; Draper B; Iqbal A; Hardiman T; Zabinski T; Man F; de Rosales RTM; Xie J; Aswad F; Achkova D; Joseph CR; Ciprut S; Adami A; Roider HG; Hess-Stumpp H; Győrffy B; Quist J; Grigoriadis A; Sommer A; Tutt ANJ; Davies DM; Maher J
    Cell Rep Med; 2021 Dec; 2(12):100473. PubMed ID: 35028614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
    Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
    J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.
    Song L; Wang Y; Sui Y; Sun J; Li D; Li G; Liu J; Li T; Shu Q
    Med Sci Monit; 2018 Aug; 24():5660-5667. PubMed ID: 30106887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
    Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
    Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.